Murphy Andrew J Insider Trades & Stock Holdings

Co-Chief Scientific Officer · Regeneron Pharmaceuticals, Inc. · Latest filing Oct 14, 2026

Murphy Andrew J, Co-Chief Scientific Officer at Regeneron Pharmaceuticals, Inc. has 1 Form 4 trade on file since Oct 14, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($3.20M), net -$3.20M. Latest filing: disposed of 4.15K shares of $REGN on Oct 14, 2026 at $772.70.

Trades on file

1

Open-market bought

$0

Open-market sold

$3.20M

Net open-market

-$3.20M

Latest filing

Oct 14, 2026

All insider trades by Murphy Andrew J

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 14, 2026	$REGN	Sell (Open-market sale) 10b5-1	4.15K	$772.70	$3.20M						Co-Chief Scientific Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Murphy Andrew J traded

• $REGN

Frequently asked questions

Has Murphy Andrew J been buying or selling stock?

Murphy Andrew J has 0 open-market purchases and 1 open-market sale on file, net -$3.20M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Murphy Andrew J's latest insider trade?

disposed of 4.15K shares of $REGN on Oct 14, 2026 at $772.70.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.